Chemokines at large: In-vivo mechanisms of their transport, presentation and clearance

Thrombosis and Haemostasis

Volumn 97, Issue 5, 2007, Pages 688-693

  Colditz, Ian G ^a   Schneider, Martin A ^b   Pruenster, Monika ^a   Rot, Antal ^b  

^a CSIRO   (Australia)

^b Novartis Institutes of BioMedical Research   (Austria)

Author keywords

Decoy; Emigration; Interceptor; Leukocyte; Receptor

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; ENZYME; G PROTEIN COUPLED RECEPTOR; GLYCOSAMINOGLYCAN;

ARTICLE; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LEUKOCYTE STRUCTURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 34249029610     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-02-0105     Document Type: Article

References (93)

1. Metchnikoff E. Lectures on the comparative pathology of inflammation. London, 1893.
2. Pfeffer W. Locomotorische Richtungsbewegungen durch chemische Reize. Untersuchungen aus dem Botanischen Institut Tübingen 1884; 1: 363-482.
3. Clark ER. Observations on changes in blood vascular endothelium in the living animal. Am J Anat 1935; 57: 385-438.
4. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-1036.
5. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
6. Luster AD, Alon R, and von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6: 1182-1190.
7. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928.
8. Cinamon G, Grabovsky V, Winter E, et al. Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol 2001; 69: 860-866.
9. Cinamon G, Shinder V, Alon R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol 2001; 2: 515-522.
10. Cuvelier SL, Patel KD. Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. J Exp Med 2001; 194: 1699-1709.
11. Schreiber T, Shinder V, Cain D, et al. Shear flow-dependent integration of apical and subendothelial chemokines in T cell transmigration: implications for locomotion and the multi-step paradigm. Blood 2007; 109: 1381-1386.
12. Colditz IG. Margination and emigration of leucocytes. Surv Synth Pathol Res 1985; 4: 44-68.
13. Doerschuk CM. Leukocyte trafficking in alveoli and airway passages. Respir Res 2000; 1: 136-140.
14. Jongstra-Bilen J, Haidari M, Zhu SN, et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 2006; 203: 2073-2083.
15. Colditz IG, Zwahlen RD, Baggiolini M. Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1. J Leukoc Biol 1990; 48: 129-137.
16. Lira SA, Zalamea P, Heinrich JN, et al. Expression of the chemokine N51/ KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J Exp Med 1994; 180: 2039-2048.
17. Lira SA. Genetic approaches to study chemokine function. J Leukoc Biol 1996; 59: 45-52.
18. Rot A. Chemotactic potency of recombinant human neutrophil attractant/ activation protein-1 (interleukin-8) for polymorphonuclear leukocytes of different species. Cytokine 1991; 3: 21-27.
19. Alam R, Kumar D, Anderson-Walters D, et al. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994; 152: 1298-1303.
20. Hub E, Rot A. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin. Am J Pathol 1998; 152: 749-757.
21. Rot A. Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. Cytokine 1992; 4: 347-352.
22. Das AM, Flower RJ, and Perretti M. Resident mast cells are important for eotaxin-induced eosinophil accumulation in vivo. J Leukoc Biol 1998; 64: 156-162.
23. Ramos CD, Canetti C, Souto JT, et al. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J Leukoc Biol 2005; 78: 167-177.
24. Wang Y, Thorlacius H. Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice. Br J Pharmacol 2005; 145: 1062-1068.
25. Johnson-Leger C and Imhof BA. Forging the endothelium during inflammation: pushing at a half-open door? Cell Tissue Res 2003; 314: 93-105.
26. Callahan MK and Ransohoff RM. Analysis of leukocyte extravasation across the blood-brain barrier: conceptual and technical aspects. Curr Allergy Asthma Rep 2004; 4: 65-73.
27. Engelhardt B, Wolburg H. Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 2004; 34: 2955-2963.
28. Hordijk PL. Endothelial signalling events during leukocyte transmigration. Febs J 2006; 273: 4408-4415.
29. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992; 13: 291-294.
30. Middleton J, Neil S, Wintle J, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997; 91: 385-395.
31. Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002; 186: 8-18.
32. Campbell JJ, Hedrick J, Zlotnik A, et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998; 279: 381-384.
33. Chan JR, Hyduk SJ, and Cybulsky MI. Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J Exp Med 2001; 193: 1149-1158.
34. Constantin G, Majeed M, Giagulli C, et al. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 2000; 13: 759-769.
35. Kohrgruber N, Groger M, Meraner P, et al. Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol 2004; 173: 6592-6602.
36. Weber KS, von Hundelshausen P, Clark-Lewis I, et al. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol 1999; 29: 700-712.
37. Weber C, Weber KS, Klier C, et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/ CD45RO(+) T cells. Blood 2001; 97: 1144-1146.
38. Hechtman DH, Cybulsky MI, Fuchs HJ, et al. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991; 147: 883-892.
39. Luscinskas FW, Kiely JM, Ding H, et al. Invitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 1992; 149: 2163-2171.
40. Martin C, Burdon PC, Bridger G, et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003; 19: 583-593.
41. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006; 7: 311-317.
42. Tanaka Y, Adams DH, Hubscher S, et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 1993; 361: 79-82.
43. Webb LM, Ehrengruber MU, Clark-Lewis I, et al. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 1993; 90: 7158-7162.
44. Ludwig A, Weber C. Transmembrane chemokines: Versatile 'special agents' in vascular inflammation. Thromb Haemost 2007; 694-703.
45. Proudfoot AE, Handel TM, Johnson Z, et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA 2003; 100: 1885-1890.
46. Wang L, Fuster M, Sriramarao P, et al. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 2005; 6: 902-910.
47. Baekkevold ES, Yamanaka T, Palframan RT, et al. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med 2001; 193: 1105-1112.
48. Nibbs R, Graham G, and Rot A. Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. Semin Immunol 2003; 15: 287-294.
49. Pruenster M, Rot A. Throwing light on DARC. Biochem Soc Trans 2006; 34: 1005-1008.
50. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 2005; 16: 687-694
51. Hadley TJ and Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997; 89: 3077-3091.
52. Hadley TJ, Lu ZH, Wasniowska K, et al. Postcapillary venule endothelial cells in kidney express a multi-specific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994; 94: 985-991.
53. Horuk R, Martin AW, Wang Z, et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 1997; 158: 2882-2890.
54. Tournamille C, Colin Y, Cartron JP, et al. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10: 224-228.
55. Miller LH, Mason SJ, Dvorak JA, et al. Erythrocyte receptors for ( Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 1975; 189: 561-563.
56. Peiper SC, Wang ZX, Neote K, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311-1317.
57. Lee JS, Frevert CW, Wurfel MM, et al. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 2003; 170: 5244-5251.
58. Bruhl H, Vielhauer V, Weiss M, et al. Expression of DARC, CXCR3 and CCR5 in giant cell arteritis. Rheumatology (Oxford) 2005; 44: 309-313.
59. Gardner L, Wilson C, Patterson AM, et al. Temporal expression pattern of Duffy antigen in rheumatoid arthritis: up-regulation in early disease. Arthritis Rheum 2006; 54: 2022-2026.
60. Lee JS, Frevert CW, Thorning DR, et al. Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia. J Histochem Cytochem 2003; 51: 159-166.
61. Liu XH, Hadley TJ, Xu L, et al. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 1999; 55: 1491-1500.
62. Patterson AM, Siddall H, Chamberlain G, et al. Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. J Pathol 2002; 197: 108-116.
63. Segerer S, Regele H, Mac KM, et al. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000; 58: 1546-1556.
64. Guyton AC, Granger HJ, and Taylor AE. Interstitial fluid pressure. Physiol Rev 1971; 51: 527-563.
65. Gretz JE, Norbury CC, Anderson AO, et al. Lymphborne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 2000; 192: 1425-1440.
66. Palframan RT, Jung S, Cheng G, et al. Inflammatory chemokine transport and presentation in BEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001; 194: 1361-1373.
67. Stein JV, Rot A, Luo Y, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000; 191: 61-76.
68. Nibbs RJ, Wylie SM, Yang J, et al. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem 1997; 272: 32078-32083.
69. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158: 867-877.
70. Fra AM, Locati M, Otero K, et al. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Inummol 2003; 170: 2279-2282.
71. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006; 6: 907-918.
72. Weber M, Blair E, Simpson CV et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 2004; 15: 2492-2508.
73. Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 2005; 6: 403-411.
74. Graham GJ, McKimmie CS. Chemokine scavenging by D6: a movable feast? Trends Immunol 2006; 27: 381-386.
75. Ariel A, Fredman G, Sun YP, et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol 2006; 7: 1209-1216.
76. D'Amico G, Frascaroli G, Bianchi G, et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 2000; 1: 387-391.
77. Dar A, Goichberg P, Shinder V, et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005; 6: 1038-1046.
78. Proost P, Struyf S, Van Damme J. Natural post-translational modifications of chemokines. Biochem Soc Trans 2006; 34: 997-1001.
79. Struyf S, Proost P, Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 2003; 81: 1-44.
80. de Beaufort AJ, Pelikan DM, Elferink JG, et al. Effect of interleukin 8 in meconium on in-vitro neutrophil chemotaxis. Lancet 1998; 352: 102-105.
81. Ohtsuki K, Hayase M, Akashi K, et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 2001; 104: 203-208.
82. Rao WH, Evans GS, Finn A. The significance of interleukin 8 in urine. Arch Dis Child 2001; 85: 256-262.
83. Rucinski B, Knight LC, Niewiarowski S. Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin. Am J Physiol 1986; 251: H800-H807.
84. Stiemer B, Buschmann A, Bisson S, et al. Interleukin-8 in urine: a new diagnostic parameter for intra-amniotic infection after premature rupture of the membranes. Br J Obstet Gynaecol 1997; 104: 499-502.
85. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
86. Dawson TC, Lentsch AB, Wang Z, et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000; 96: 1681-1684.
87. Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261: 1182-1184.
88. Neote K, Darbonne W, Ogez J, et al. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268: 12247-12249.
89. Fukuma N, Akimitsu N, Hamamoto H, et al. A role ofthe Duffy antigen for the maintenance ofplasma chemokine concentrations. Biochem Biophys Res Commun 2003; 303: 137-139.
90. Lee JS, Wurfel MM, Matute-Bello G, et al. The Duffy Antigen Modifies Systemic and Local Tissue Chemokine Responses following Lipopolysaccharide Stimulation. J Immunol 2006; 177: 8086-8094.
91. Jones AP, Webb LM, Anderson AO, et al. Normal human sweat contains interleukin-8. J Leukoc Biol 1995; 57: 434-437.
92. Michie CA, Tantscher E, Schall T, et al. Physiological secretion of chemokines in human breast milk. Eur Cytokine Netw 1998; 9: 123-129.
93. Rot A, Jones AP, Webb LM. Some aspects of NAPI/IL-8 pathophysiology. II: Chemokine secretion by exocrine glands. Adv Exp Med Biol 1993; 351: 77-85.